Cell therapy of diabetes

Advances in Experimental Medicine and Biology

Volumn 552, Issue , 2004, Pages 16-38

  Jensen, Jan Nygaard ^a   Jensen, Jan ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIN; INSULIN; NESTIN;

ADOPTIVE IMMUNOTHERAPY; ALLOTRANSPLANTATION; CELL CLONING; CELL DIFFERENTIATION; CELL REGENERATION; EMBRYONIC STEM CELL; ENDOCRINE TUMOR; HOMEOSTASIS; HUMAN; HUMAN CLONING; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; LIVER; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS DISEASE; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PANCREAS RESECTION; PANCREATITIS; PLASTICITY; PRIORITY JOURNAL; REVIEW; TUMOR CELL; XENOTRANSPLANTATION;

ANIMALS; CELL LINEAGE; DIABETES MELLITUS; EMBRYO; HUMANS; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MODELS, BIOLOGICAL; PANCREAS; REGENERATION; STEM CELLS; TISSUE THERAPY;

EID: 11844302919     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (100)

1. Vogel G. Can old cells learn new tricks? Science 2000; 287(5457):1418-1419.
2. Jones DB, Gill GV. Insulin dependent diabetes mellitus. In: Pickup J, Williams G, eds. Textbook of Diabetes. Blackwell Science, 1997.
3. Shapiro AM, Ryan EA, Lakey JR. Pancreatic islet transplantation in the treatment of diabetes mellitus. Best Pract Res Clin Endocrinol Metab 2001; 15(2):241-264.
4. Kruszynska YT. Normal metabolism: The physioogy of fuel homeostasis. In: Pickup J, Williams G, eds. Textbook of Diabetes. Blackwell Science, 1997.
5. Grupe A, Hultgren B, Ryan A et al. Transgenic knockouts reveal a critical requirement for pancreatic beta-cell glucokinase in maintaining glucose-homeostasis. Cell 1995; 83(1):-69.
6. Hanke J. Apoptosis and occurrence of Bcl-2, Bak, Bax, Fas and FasL in the developing and adult rat endocrine pancreas. Anat Embryol (Berl) 2000; 202(4):303-312.
7. Weir GC, Laybutt DR, Kaneto H et al. Beta-cell adaptation and decompensation during the progression of diabetes. Diabetes 2001; 50 Suppl 1:S154-S159.
8. Steil GM, Trivedi N, Jonas JC et al. Adaptation of beta-cell mass to substrate oversupply: Enhanced function with normal gene expression. Am J Physiol Endocrinol Metab 2001; 280(5):E788-E796.
9. Biarnes M, Montolio M, Nacher V et al. Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia. Diabetes 2002; 51(1):66-72.
10. Yki-Jarvinen H, Williams G. Insulin resistance in noninsulin dependent diabetes mellitus. In: Pickup J, Williams G, eds. Textbook of Diabetes. Blackwell Science, 1997.
11. Thomas PM, Cote GJ, Wohllk N et al. The molecular basis for familial persistent hyperinsulinemic hypoglycemia of infancy. Proc Assoc Am Physicians 1996; 108(1):14-19.
12. Thomas PM, Cote GJ, Wohllk N et al. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science 1995; 268(5209):426-429.
13. Thomas P, Ye Y, Lightner E. Mutation of the pancreatic islet inward rectifier Kir6.2 also leads to familial persistent hyperinsulinemic hypoglycemia of infancy. Hum Mol Genet 1996; 5(11):1809-1812.
14. Sako Y, Grill VE. Coupling of beta-cell desensitization by hyperglycemia to excessive stimulation and circulating insulin in glucose-infused rats. Diabetes 1990; 39(12):1580-1583.
15. Leahy JL. b-cell dysfunction and chronic hyperglycaemia. In: Habener JF, Hussar n MA, eds. Molecular basis of pancreas development and function. Kluwer Academic Press, 2001:35-46.
16. Johannesen J, Pociot F, Karlsen AE et al. Strain-dependent difference in inducible nitric oxide synthesis (iNOS) expression in rat pancreatic islets correlates with Interferon regulating factor 1 (IRF-1) and heat shock protein 70 (HSP70) expression. Eur Cytokine Netw 2001; 12(3):501-509.
17. Nielsen K, Karlsen AE, Decken M et al. Beta-cell maturation leads to in vitro sensitivity to cytotoxins. Diabetes 1999; 48(12):2324-2332.
18. Chervonsky AV, Wang Y, Wong FS et al. The role of Fas in autoimmune diabetes. Cell 1997; 89(1):17-24.
19. Nielsen JH, Svensson C, Galsgaard ED. Beta cell proliferation and growth factors. J Mol Med 1999; 77(1):62-66.
20. Stout LE, Svensson AM, Sorenson RL. Prolactin regulation of islet-derived INS-1 cells: Characteristics and immunocytochemical analysis of STAT5 translocation. Endocrinology 1997; 138(4):1592-1603.
21. Billestrup N, Nielsen JH. The stimulatory effect of growth hormone, prolactin, and placental lactogen on beta-cell proliferation is not mediated by insulin-like growth factor-I. Endocrinology 1991; 129(2):883-888.
22. Brelje TC, Sorenson RL. Role of prolactin versus growth hormone on islet B-cell proliferation in vitro: Implications for pregnancy. Endocrinology 1991; 128(1):45-57.
23. Hill DJ, Hogg J. Growth factor control of pancreatic B cell hyperplasia. Baillieres Clin Endocrinol Metab 1991; 5(4):689-698.
24. Miettinen PJ, Otonkoski T, Voutilainen R. Insulin-like growth factor-II and transforming growth factor-alpha in developing human fetal pancreatic islets. J Endocrinol 1993; 138(1):127-136.
25. Petrik J, Pell JM, Arany E et al. Overexpression of insulin-like growth factor-II in transgenic mice is associated with pancreatic islet cell hyperplasia. Endocrinology 1999; 140(5):2353-2363.
26. Kassem SA, Ariel I, Thornton PS et al. p57(KIP2) expression in normal islet cells and in hyperinsulinism of infancy. Diabetes 2001; 50(12):2763-2769.
27. Tuttle RL, Gill NS, Pugh W et al. Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha. Nat Med 2001; 7(10):1133-1137.
28. Garcia-Ocana A, Takane KK, Syed MA. Hepatocyte growth factor overexpression in the islet of transgenic mice increases beta cell proliferation, enhances islet mass, and induces mild hypoglycemia. J Biol Chem 2000; 275(2):1226-1232.
29. Stoffers DA, Kieffer TJ, Hussain MA et al. Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. Diabetes 2000; 49(5):741-748.
30. Xu G, Stoffers DA, Habener JF et al. Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes 1999; 48(12):2270-2276.
31. Trumper A, Trumper K, Trusheim H et al. Glucose-dependent insulinotropic polypeptide is a growth factor for beta (INS-1) cells by pleiotropic signaling. Mo1 Endocrinol 2001; 15(9):1559-1570.
32. Rane SG, Dubus P, Mettus RV et al. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia. Nat Genet 1999; 22(1):44-52.
33. Wobus AM. Potential of embryonic stem cells. Mol Aspects Med 2001; 22(3):149-164.
34. Soria B, Roche E, Berna G et al. Martin F. Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 2000; 49(2):157-162.
35. Soria B, Skoudy A, Martin F. From stem cells to beta cells: New strategies in cell therapy of diabetes mellitus. Diabetologia 2001; 44(4):407-415.
36. Lumelsky N, Blondel O, Laeng P et al. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 2001; 292(5520):1389-1394.
37. Solter D, Gearhart J. Putting stem cells to work. Science 1999; 283(5407):1468-1470.
38. Wakayama T, Tabar V, Rodriguez I et al. Differentiation of embryonic stem cell lines generated from adult somatic cells by nuclear transfer. Science 2001; 292(5517):740-743.
39. Surani MA. Reprogramming of genome function through epigenetic inheritance. Nature 2001; 414(6859):122-128.
40. Kondo M, Weissman IL, Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 1997; 91(5):661-672.
41. Krause DS, Theise ND, Collector MI et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 2001; 105(3):369-377.
42. Jones PH, Harper S, Watt FM. Stem cell patterning and fate in human epidermis. Cell 1995; 80(1):83-93.
43. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284(5411):143-147.
44. Rietze RL, Valcanis H, Brooker GF et al. Purification of a pluripotent neural stem cell from the adult mouse brain. Nature 2001; 412(6848):736-739.
45. Mezey E, Chandross KJ, Harta G et al. Turning blood into brain: Cells bearing neuronal antigens generated in vivo from bone marrow. Science 2000; 290(5497):1779-1782.
46. Clarke DL, Johansson CB, Wilbertz J et al. Generalized potential of adult neural stem cells. Science 2000; 288(5471):1660-1663.
47. Mezey E, Chandross KJ. Bone marrow: A possible alternative source of cells in the adult nervous system. Eur J Pharmacol 2000; 405(1-3):297-302.
48. Suzuki A, Zheng Yw YW, Kaneko S et al. Clonal identification and characterization of self-renewing pluripotent stem cells in the developing liver. J Cell Biol 2002; 156(1):173-184.
49. Zaret KS. Liver specification and early morphogenesis. Mech Dev 2000; 92(1):83-88.
50. Zaret KS. Hepatocyte differentiation: From the endoderm and beyond. Curr Opin Genet Dev 2001; 11(5):568-574.
51. Deutsch G, Jung JN, Zheng MH et al. A bipotential precursor population for pancreas and liver within the embryonic endoderm. Development 2001; 128(6):871-881.
52. Rao MS, Subbarao V, Reddy JK. Induction of hepatocytes in the pancreas of copper-depleted rats following copper repletion. Cell Differ 1986; 18(2):109-117.
53. Rao MS, Dwivedi RS, Yeldandi AV et al. Role of periductal and ductular epithelial cells of the adult rat pancreas in pancreatic hepatocyte lineage. A change in the differentiation commitment. Am J Pathol 1989; 134(5):1069-1086.
54. Rao MS, Reddy JK. Hepatic transdifferentiation in the pancreas. Semin Cell Biol 1995; 6(3):151-156.
55. Shen CN, Slack JM, Tosh D. Molecular basis of transdifferentiation of pancreas to liver. Nat Cell Biol 2000; 2(12):879-887.
56. Paner GP, Thompson KS, Reyes CV. Hepatoid carcinoma of the pancreas. Cancer 2000; 88(7):1582-1589.
57. Jacquemin P, Durviaux SM, Jensen J et al. Transcription factor hepatocyte nuclear factor 6 regulates pancreatic endocrine cell differentiation and controls expression of the proendocrine gene ngn3. Mol Cell B 2000; 20(12):4445-4454.
58. Ben Shushan E, Marshak S, Shoshkes M et al. A pancreatic beta-cell-specific enhancer in the human PIX-1 gene is regulated by hepatocyte nuclear factor 3 beta (HNF-3 beta), HNF-1 alpha, and SPs transcription factors. J Biol Chem 2001; 276(20):17533-17540.
59. Jacquemin P, Durviaux SM, Jensen J et al. The transcription factor HNF-6 regulates pancreatic endocrine cell differentiation and controls the expression of the pro-endocrine gene ngn3. Molecular And Cellular Biology 2000; In press.
60. Gauthier BR, Schwitzgebel VM, Zaiko M et al. Hepatic Nuclear Factor-3 (HNF-3 or Foxa2) Regulates Glucagon Gene Transcription by Binding to the G1 and G2 Promoter Elements. Mol Endocrinol 2002; 16(1):170-183.
61. Pontoglio M, Sreenan S, Roe M et al. Defective insulin secretion in hepatocyte nuclear factor 1alpha- deficient mice. J Clin Invest 1998; 101(10):2215-2222.
62. Shen W, Scearce LM, Brestelli JE et al. Foxa3 (hepatocyte nuclear factor 3gamma) is required for the regulation of hepatic GLUT2 expression and the maintenance of glucose homeostasis during a prolonged fast. J Biol Chem 2001; 276(46):42812-42817.
63. Sladek FM, Dallas-Yang Q, Nepomuceno L. MODY1 mutation Q268X in hepatocyte nuclear factor 4alpha allows for dimerization in solution but causes abnormal subcellular localization. Diabetes 1998; 47(6):985-990.
64. Ferber S, Halkin A, Cohen H et al. Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat Med 2000; 6(5):568-572.
65. Bartlett RJ, Secore SL, Denis M et al. Toward the biologic release of human insulin from skeletal muscle. Transplant Proc 1997; 29(4):2199-2200.
66. Bochan MR, Sidner RA, Shah R et al. Stable transduction of human pancreatic adenocarcinoma cells, rat fibroblasts, and bone marrow-derived stem cells with recombinant adeno- associated virus containing the rat preproinsulin II gene. Transplant Proc 1998; 30(2):453-454.
67. Lipes MA, Davalli AM, Cooper EM. Genetic engineering of insulin expression in nonislet cells: Implications for beta-cell replacement therapy for insulin-dependent diabetes mellitus. Acta Diabetol 1997; 34(1):2-5.
68. Falqui L, Martinenghi S, Berra C et al. Human proinsulin production in primary rat hepatocytes after retroviral vector gene transfer. J Mol Med 1999; 77(1):250-253.
69. Goldfine ID, German MS, Tseng HC et al. The endocrine secretion of human insulin and growth hormone by exocrine glands of the gastrointestinal tract. Nat Biotechnol 1997; 15(13):1378-1382.
70. Cheung AT, Dayanandan B, Lewis JT et al. Glucose-dependent insulin release from genetically engineered K cells. Science 2000; 290(5498):1959-1962.
71. de la TD, Halvorsen T, Demeterco C et al. Beta-cell differentiation from a human pancreatic cell line in vitro and in vivo. Mol Endocrinol 2001; 15(3):476-483.
72. Demeterco C, Levine F. Gene therapy for diabetes. Front Biosci 2001; 6:D175-D191.
73. Itkin-Ansari P, Demeterco C, Bossie S et al. PDX-1 and cell-cell contact act in synergy to promote delta-cell development in a human pancreatic endocrine precursor cell line. Mol Endocrinol 2000; 14(6):814-822.
74. Levine F, Leibowitz G. Towards gene therapy of diabetes mellitus. Mol Med Today 1999; 5(4):165-171.
75. Efrat S, Linde S, Kofod H et al. Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene. Proc Natl Acad Sci USA 1988; 85(23):9037-9041.
76. Efrat S. Genetically engineered pancreatic beta-cell lines for cell therapy of diabetes. Ann NY Acad Sci 1999; 875:286-293.
77. Fleischer N, Chen C, Surana M et al. Functional analysis of a conditionally transformed pancreatic beta-cell line. Diabetes 1998; 47(9):1419-1425.
78. Hunziker E, Stein M. Nestin-expressing cells in the pancreatic islets of Langerhans. Biochem Biophys Res Commun 2000; 271(1):116-119.
79. Zulewski H, Abraham EJ, Gerlach MJ et al. Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes 2001; 50(3):521-533.
80. Bonner-Weir S. beta-cell turnover: Its assessment and implications. Diabetes 2001; 50 Suppl 1:S20-S24.
81. Krakowski ML, Kritzik MR, Jones EM et al. Transgenic expression of epidermal growth factor and keratinocyte growth factor in beta-cells results in substantial morphological changes. J Endocrinol 1999; 162(2):167-175.
82. Gu D, Lee MS, Krahl T et al. Transitional cells in the regenerating pancreas. Development 1994; 120(7):1873-1881.
83. Bonner-Weir S, Taneja M, Weir GC et al. In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci USA 2000; 97(14):7999-8004.
84. Sharma A, Zangen DH, Reitz P et al. The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration. Diabetes 1999; 48(3):507-513.
85. Bonner-Weir S, Baxter LA, Schuppin GT et al. A second pathway for regeneration of adult exocrine and endocrine pancreas. A possible recapitulation of embryonic development. Diabetes 1993; 42(12):1715-1720.
86. Pictet R, Rutter WJ. Development of the embryonic endocrine pancreas. In: Steiner DF, Freinkel N, eds. Handbook of Physiology, section 7: Endocrinology, Vol. 1. Washington DC: American Physiological Society, 1972:25-66.
87. Niederau C, Niederau M, Luthen R et al. Pancreatic exocrine secretion in acute experimental pancreatitis. Gastroenterology 1990; 99(4):1120-1127.
88. Rodriguez AI, De DI, Garcia-Montero AC et al. Acute necrotizing pancreatitis induced by a CDE diet in the rat: A morphologic and functional study. J Lab Clin Med 1994; 123(5):693-700.
89. Walker NI, Winterford CM, Williamson RM et al. Ethionine-induced atrophy of rat pancreas involves apoptosis of acinar cells. Pancreas 1993; 8(4):443-449.
90. Kusske AM, Rongione AJ, Ashley SW et al. Interleukin-10 prevents death in lethal necrotizing pancreatitis in mice. Surgery 1996; 120(2):284-288.
91. Capdevila A, Decha-Umphai W, Song KH et al. Pancreatic exocrine secretion is blocked by inhibitors of methylation. Arch Biochem Biophys 1997; 345(1):47-55.
92. Portha B, Blondel O, Serradas P et al. The rat models of noninsulin dependent diabetes induced by neonatal streptozotocin. Diabete Metab 1989; 15(2):61-75.
93. Apelqvist A, Li H, Sommer L et al. Notch signalling controls pancreatic cell differentiation. Nature 1999; 400(6747):877-881.
94. Gradwohl G, Dierich A, LeMeur M et al. neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc Natl Acad Sci USA 2000; 97(4):1607-1611.
95. Sosa-Pineda B, Chowdhury K, Torres M et al. The Pax4 gene is essential for differentiation of insulin- producing beta cells in the mammalian pancreas. Nature 1997; 386(6623):399-402.
96. Jonsson J, Carlsson L, Edlund T et al. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 1994; 371 (6498):606-609.
97. Sander M, Sussel L, Conners J et al. Homeobox gene Nkx6.1 lies downstream of Nkx2.2 in the major pathway of beta-cell formation in the pancreas. Development 2000; 127(24):5533-5540.
98. Sussel L, Kalamaras J, Hartigan-O'Connor DJ et al. Mice lacking the homeodomain transcription factor Nkx2.2 have diabetes due to arrested differentiation of pancreatic beta cells. Development 1998; 125(12):2213-2221.
99. Bhushan A, Itoh N, Kato S et al. Fgf10 is essential for maintaining the proliferative capacity of epithelial progenitor cells during early pancreatic organogenesis. Development 2001; 128(24):5109-5117.
100. Jensen J, Pedersen EE, Galante P et al. Control of endodermal endocrine development by Hes-1. Nat Genet 2000; 24(1):36-44.